Regarding $300M....btw the technology has improved
Post# of 36537
(Total Views: 179)
Posted On: 11/12/2019 8:01:33 PM
Regarding $300M....btw the technology has improved since 2011...that's why I thought $300M was a very reasonable conservative estimate for NGIO...
_________
Per 6/21/19 cc, Joe said this -
"Oral-lyn, you know, you have Dr. Andy Anderson on the team. Dr. Anderson
is a legend, you know, in the industry, and he reformulated Oral-lyn from
seven to ten-puffs, which in my opinion back then from a utility standpoint
was never a good product because of the cost versus subcutaneous injection.
For me, he reformulated, you know, Oral-lyn down to one-to-two puffs now.
It’s a much more, better acting as well as formulated product. We will get
back to that."
_________
Per 6/21/19 cc, Joe said this -
"Oral-lyn, you know, you have Dr. Andy Anderson on the team. Dr. Anderson
is a legend, you know, in the industry, and he reformulated Oral-lyn from
seven to ten-puffs, which in my opinion back then from a utility standpoint
was never a good product because of the cost versus subcutaneous injection.
For me, he reformulated, you know, Oral-lyn down to one-to-two puffs now.
It’s a much more, better acting as well as formulated product. We will get
back to that."
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼